Literature DB >> 1069309

Dichloromethane as an antisickling agent in sickle cell hemoglobin.

B P Schoenborn.   

Abstract

Microscopic studies of red cells from homozygous sickle cell patients show that dichloromethane does prevent sickle cell formation in vitro and does cause reversion of sickled cells to normal after exposure to dichloromethane. X-ray structural analysis of human deoxyhemoglobin crystals exposed to dichloromethane shows four unique binding sites. Arguments are presented to suggest that the binding site close to tryptophan 14alpha prevents the formation of helical polymers, i.e., prevent sickling.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1069309      PMCID: PMC431382          DOI: 10.1073/pnas.73.11.4195

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  A new approach to the treatment of sickle cell anemia.

Authors:  A Milosz; W Settle
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-09

2.  A MOLECULAR MECHANISM OF SICKLED ERYTHROCYTE FORMATION.

Authors:  M MURAYAMA
Journal:  Nature       Date:  1964-04-18       Impact factor: 49.962

3.  Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin.

Authors:  V M INGRAM
Journal:  Nature       Date:  1957-08-17       Impact factor: 49.962

4.  alpha-Chain contacts in the polymerisation of sickle haemogloblin.

Authors:  R E Benesch; S Yung; R Benesch; J Mack; R G Schneider
Journal:  Nature       Date:  1976-03-18       Impact factor: 49.962

5.  Polymorphism of sickle cell hemoglobin fibers.

Authors:  R Josephs; H S Jarosch; S J Edelstein
Journal:  J Mol Biol       Date:  1976-04-15       Impact factor: 5.469

6.  Intermolecular organization of deoxygenated sickle haemoglobin determined by x-ray diffraction.

Authors:  B Magdoff-Fairchild; P H Swerdlow; J F Bertles
Journal:  Nature       Date:  1972-09-22       Impact factor: 49.962

7.  Structure of sickled erythrocytes and of sickle-cell hemoglobin fibers.

Authors:  J T Finch; M F Perutz; J F Bertles; J Döbler
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

8.  Stereochemistry of cooperative effects in hemoglobin.

Authors:  M F Perutz; L F TenEyck
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1972

9.  Dichloromethane and myoglobin function.

Authors:  A C Nunes; B P Schoenborn
Journal:  Mol Pharmacol       Date:  1973-11       Impact factor: 4.436

10.  The interactions of sickle hemoglobin.

Authors:  H M Ranney
Journal:  Biochimie       Date:  1972       Impact factor: 4.079

View more
  6 in total

1.  Structural basis for the inhibition of firefly luciferase by a general anesthetic.

Authors:  N P Franks; A Jenkins; E Conti; W R Lieb; P Brick
Journal:  Biophys J       Date:  1998-11       Impact factor: 4.033

2.  Proposed mechanistic description of dose-dependent BDE-47 urinary elimination in mice using a physiologically based pharmacokinetic model.

Authors:  Claude Emond; J Michael Sanders; Daniele Wikoff; Linda S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  2013-09-19       Impact factor: 4.219

3.  Physiological and x-ray studies of potential antisickling agents.

Authors:  D J Abraham; M F Perutz; S E Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

4.  Stereospecific dihaloalkane binding in a pH-sensitive cavity in cubic insulin crystals.

Authors:  O Gursky; E Fontano; B Bhyravbhatla; D L Caspar
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

5.  Dichloromethane and carbon monoxide inhalation: carboxyhemoglobin addition, and drug metabolizing enzymes in rat.

Authors:  K Kurppa; H Kivistö; H Vainio
Journal:  Int Arch Occup Environ Health       Date:  1981       Impact factor: 3.015

6.  Differential halothane binding and effects on serum albumin and myoglobin.

Authors:  R G Eckenhoff; J W Tanner
Journal:  Biophys J       Date:  1998-07       Impact factor: 4.033

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.